Literature DB >> 312908

CBA/N X-linked B-cell defect prevents NZB B-cell hyperactivity in F1 mice.

J D Taurog, H M Moutsopoulos, Y J Rosenberg, T M Chused, A D Steinberg.   

Abstract

NZB mice and their F1 hybrids produce excessive polyclonal IgM and autoantibodies of both IgM and IgG classes. CBA/N mice and CBA/N-mothered F1 males fail to make antibody to many T-independent antigens and have low levels of serum IgM; further, these mice lack a population of splenic B cells characterized by a low-to-intermediate density of surface IgM. We have studied male CBA/N, NZB, CBA/N X NZB, NZB X CBA/N, and CBA/J mice; female CBA/N X NZB mice; and males of several control crosses of NZB and CBA/N mice. We have found that the CBA/N X-linked defect of T-independent immune response is completely expressed in CBA/N X NZB mice. In marked contrast to NZB mice and to NZB mice and to NZB F1 hybrids bearing at least one normal X chromosome, the CBA/N X NZB males failed to respond to two T-independent antigens, had small numbers of splenic IgM-producing cells, barely detectable splenic IgM production, and splenic B-cell surface-Ig patterns resembling those of CBA/N mice. These data suggest that the NZB B-cell abnormality resulting in excessive IgM production occurs almost exclusively in that population of B cells affected by the CBA/N X chromome-linked defect. Preliminary studies suggest that CBA/N X chromosome retards the spontaneous development of anti-erythrocyte autoantibodies in CBA/N X NZB males. Castration, known to accelerate autoimmune disease in certain NZB F1 males, appears to have no influence on the immune functions examined in this study.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312908      PMCID: PMC2185603          DOI: 10.1084/jem.150.1.31

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

1.  THE INHERITANCE OF AUTOIMMUNE DISEASE IN MICE: A STUDY OF HYBRIDS OF THE STRAINS NZB AND C3H.

Authors:  M C HOLMES; F M BURNET
Journal:  Heredity (Edinb)       Date:  1964-08       Impact factor: 3.821

2.  Surface immunoglobulins of lipopolysaccharide-stimulated spleen cells. The behavior of IgM, IgD and IgG.

Authors:  A Bourgois; K Kitajima; I R Hunter; B A Askonas
Journal:  Eur J Immunol       Date:  1977-03       Impact factor: 5.532

3.  Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease.

Authors:  S Izui; P J McConahey; F J Dixon
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

4.  Demonstration of activation of B lymphocytes in New Zealand black mice at birth by an immunoradiometric assay for murine IgM.

Authors:  H M Moutsopoulos; M Boehm-Truitt; S S Kassan; T M Chused
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

5.  Evidence for a B lymphocyte defect underlying the anti-X anti-erythrocyte autoantibody response of NZB mice.

Authors:  D H DeHeer; T S Edgington
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

6.  Modification of murine lupus by sex hormones.

Authors:  K A Melez; J P Reeves; A D Steinberg
Journal:  Ann Immunol (Paris)       Date:  1978 Jul-Sep

7.  Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice.

Authors:  J R Roubinian; N Talal; J S Greenspan; J R Goodman; P K Siiteri
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

8.  Genetic studies in NZB mice. I. Spontaneous autoantibody production.

Authors:  E S Raveché; A D Steinberg; L W Klassen; J H Tjio
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

9.  Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice.

Authors:  H Cantor; L McVay-Boudreau; J Hugenberger; K Naidorf; F W Shen; R K Gershon
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  13 in total

1.  Proliferative responsiveness of B cells from autoimmune NZB mice to anti-immunoglobulin and interleukin-4.

Authors:  M Hatakeyama; N Minato; S Kano
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

2.  Btk dosage determines sensitivity to B cell antigen receptor cross-linking.

Authors:  A B Satterthwaite; H Cheroutre; W N Khan; P Sideras; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 3.  Autoimmune diseases: immunopathology and etiopathogenesis.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

Review 4.  The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.

Authors:  Leslie J Crofford; Lindsay E Nyhoff; Jonathan H Sheehan; Peggy L Kendall
Journal:  Expert Rev Clin Immunol       Date:  2016-03-04       Impact factor: 4.473

5.  Anti-mouse red blood cell monoclonal antibodies use functionally rearranged genes from the VH J558 family and are derived from the CD5- B-lymphocyte subpopulation.

Authors:  B B Scott; S Sadigh; M Stow; R A Mageed; E M Andrew; R N Maini
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

6.  Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA.

Authors:  B J Steinberg; P A Smathers; K Frederiksen; A D Steinberg
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

7.  Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice.

Authors:  A N Theofilopoulos; D L Shawler; R A Eisenberg; F J Dixon
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

8.  Inhibition of in vitro NZB antibody responses by cyclosporine.

Authors:  D S Pisetsky
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

9.  Specific anti-erythrocyte focus formation as a measure of autoantibody secreting cells in NZB mice.

Authors:  J Moore; C Calkins
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

10.  The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells.

Authors:  Betty Y Chang; Min Mei Huang; Michelle Francesco; Jun Chen; Jeremy Sokolove; Padmaja Magadala; William H Robinson; Joseph J Buggy
Journal:  Arthritis Res Ther       Date:  2011-07-13       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.